UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15( d ) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
  Commission File Number  
0-24635
 
Hypertension Diagnostics, Inc.
(Exact name of registrant as specified in its charter)
 
10501 Wayzata Boulevard, Suite 102, Minnetonka, MN 55305, (952) 545-2457
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, $0.01 par value per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
x
Rule 12g-4(a)(2)
x
Rule 12h-3(b)(1)(i)
o
Rule 12h-3(b)(1)(ii)
o
Rule 15d-6
o

Approximate number of holders of record of the classes of the securities covered by this Form as of the certification or notice date: 146  
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Hypertension Diagnostics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date: June 10, 2014
By:
/s/  Kenneth W. Brimmer  
   
Kenneth W. Brimmer
Chief Executive Officer
 
 
 
 
Hypertension Diagnositc (CE) (USOTC:HDII)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Hypertension Diagnositc (CE) Charts.
Hypertension Diagnositc (CE) (USOTC:HDII)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Hypertension Diagnositc (CE) Charts.